465 related articles for article (PubMed ID: 31486295)
21. Gadolinium contrast agents - are they really safe?
Malikova H; Holesta M
J Vasc Access; 2017 Mar; 18(Suppl. 2):1-7. PubMed ID: 28362042
[TBL] [Abstract][Full Text] [Related]
22. MR Imaging Safety Considerations of Gadolinium-Based Contrast Agents: Gadolinium Retention and Nephrogenic Systemic Fibrosis.
McDonald JS; McDonald RJ
Magn Reson Imaging Clin N Am; 2020 Nov; 28(4):497-507. PubMed ID: 33040991
[TBL] [Abstract][Full Text] [Related]
23. Gadolinium Retention in Erythrocytes and Leukocytes From Human and Murine Blood Upon Treatment With Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging.
Di Gregorio E; Furlan C; Atlante S; Stefania R; Gianolio E; Aime S
Invest Radiol; 2020 Jan; 55(1):30-37. PubMed ID: 31503081
[TBL] [Abstract][Full Text] [Related]
24. Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion.
Lancelot E
Invest Radiol; 2016 Nov; 51(11):691-700. PubMed ID: 27175546
[TBL] [Abstract][Full Text] [Related]
25. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
[TBL] [Abstract][Full Text] [Related]
26. [Physico-chemical and toxicological profile of gadolinium chelates as contrast agents for magnetic resonance imaging].
Idée JM; Fretellier N; Thurnher MM; Bonnemain B; Corot C
Ann Pharm Fr; 2015 Jul; 73(4):266-76. PubMed ID: 25731664
[TBL] [Abstract][Full Text] [Related]
27. Can gadolinium be re-chelated in vivo? Considerations from decorporation therapy.
Prybylski JP; Semelka RC; Jay M
Magn Reson Imaging; 2016 Dec; 34(10):1391-1393. PubMed ID: 27530538
[TBL] [Abstract][Full Text] [Related]
28. Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
Sato T; Ito K; Tamada T; Kanki A; Watanabe S; Nishimura H; Tanimoto D; Higashi H; Yamamoto A
Magn Reson Imaging; 2013 Oct; 31(8):1412-7. PubMed ID: 23643157
[TBL] [Abstract][Full Text] [Related]
29. Biodistribution of gadolinium-based contrast agents, including gadolinium deposition.
Aime S; Caravan P
J Magn Reson Imaging; 2009 Dec; 30(6):1259-67. PubMed ID: 19938038
[TBL] [Abstract][Full Text] [Related]
30. Stimuli-Responsive Biodegradable Hyperbranched Polymer-Gadolinium Conjugates as Efficient and Biocompatible Nanoscale Magnetic Resonance Imaging Contrast Agents.
Sun L; Li X; Wei X; Luo Q; Guan P; Wu M; Zhu H; Luo K; Gong Q
ACS Appl Mater Interfaces; 2016 Apr; 8(16):10499-512. PubMed ID: 27043102
[TBL] [Abstract][Full Text] [Related]
31. Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms.
Rogosnitzky M; Branch S
Biometals; 2016 Jun; 29(3):365-76. PubMed ID: 27053146
[TBL] [Abstract][Full Text] [Related]
32. Gadolinium(III)-based Polymeric Magnetic Resonance Imaging Agents for Tumor Imaging.
Zu G; Kuang Y; Dong J; Cao Y; Zhang T; Liu M; Luo L; Pei R
Curr Med Chem; 2018; 25(25):2910-2937. PubMed ID: 28292237
[TBL] [Abstract][Full Text] [Related]
33. MRI gadolinium-based contrast agents. Radiologists beware!
Goullé JP; Cattanéo A; Saussereau E; Mahieu L; Guerbet M; Lacroix C
Ann Pharm Fr; 2009 Sep; 67(5):335-9. PubMed ID: 19695369
[TBL] [Abstract][Full Text] [Related]
34. Iron(iii) chelated paramagnetic polymeric nanoparticle formulation as a next-generation
Marasini R; Rayamajhi S; Moreno-Sanchez A; Aryal S
RSC Adv; 2021 Sep; 11(51):32216-32226. PubMed ID: 35495502
[TBL] [Abstract][Full Text] [Related]
35. Gadolinium-containing MRI contrast agents: important variations on a theme for NSF.
Kuo PH
J Am Coll Radiol; 2008 Jan; 5(1):29-35. PubMed ID: 18180006
[TBL] [Abstract][Full Text] [Related]
36. Update on Gadolinium Based Contrast Agent Safety, From the
Starekova J; Pirasteh A; Reeder SB
AJR Am J Roentgenol; 2023 Oct; ():. PubMed ID: 37850581
[TBL] [Abstract][Full Text] [Related]
37. Delayed Gadolinium-enhanced MR Imaging of Cartilage: A Comparative Analysis of Different Gadolinium-based Contrast Agents in an ex Vivo Porcine Model.
Kang Y; Choi JY; Yoo HJ; Hong SH; Kang HS
Radiology; 2017 Mar; 282(3):734-742. PubMed ID: 27649101
[TBL] [Abstract][Full Text] [Related]
38. Erythrocyte membrane concealed paramagnetic polymeric nanoparticle for contrast-enhanced magnetic resonance imaging.
Nguyen TDT; Marasini R; Rayamajhi S; Aparicio C; Biller D; Aryal S
Nanoscale; 2020 Feb; 12(6):4137-4149. PubMed ID: 32022084
[TBL] [Abstract][Full Text] [Related]
39. Exposure of Macrophages to Low-Dose Gadolinium-Based Contrast Medium: Impact on Oxidative Stress and Cytokines Production.
Weng TI; Chen HJ; Lu CW; Ho YC; Wu JL; Liu SH; Hsiao JK
Contrast Media Mol Imaging; 2018; 2018():3535769. PubMed ID: 30627059
[TBL] [Abstract][Full Text] [Related]
40. Nanotemplate-engineered nanoparticles containing gadolinium for magnetic resonance imaging of tumors.
Zhu D; Lu X; Hardy PA; Leggas M; Jay M
Invest Radiol; 2008 Feb; 43(2):129-40. PubMed ID: 18197065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
